A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
| Main Author: | Khan, Muidul Hasan |
|---|---|
| Other Authors: | Khair, Nishat Zareen |
| Format: | Thesis |
| Language: | English |
| Published: |
Brac University
2024
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10361/23233 |
Similar Items
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
by: Flora, Sanzida Alam
Published: (2024) -
Detection of acute Lymphocytic Leukemia (ALL) and its type by image processing and machine learning
by: Chowdhury, Himadri, et al.
Published: (2019) -
A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
by: Sorno, Rubina Haque
Published: (2024) -
CAR-T cell Therapy in B-cell Lymphoma
by: Faruk, Asef
Published: (2020) -
A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
by: Choki, Kinley
Published: (2024)